No matter what your stage of research, you can find the resources and learning materials you need to overcome obstacles and advance your cell therapy knowledge.
Webinars
Approaches to implementing automation in cell therapy manufacturing
In this webinar, David James from Scinogy, Fred Parietti from Multiply Labs, and Betty Woo from Thermo Fisher Scientific, share valuable insights on the evolution of automation processes, designing or sourcing instruments to support your process, and regulatory compliant workflows.
Strategic partnering to enable cell therapy commercialization
Cell therapy manufacturing leaders discuss the challenges of commercializing cell therapies. Learn how manufacturing innovations, industry partnerships, and more can help you optimize your processes and accelerate your commercialization journey.
Scaling nonviral cell therapy approaches for solid tumor treatments
Learn how PACT Pharma Inc. revolutionized a nonviral precision genome engineering process through automation and standardization of the end-to-end cell therapy manufacturing workflow.
A closed, modular approach to CAR T cell therapy manufacturing
In this video, you'll get a step‑by‑step overview on how to use Thermo Fisher Scientific's digitally compatible, GMP‑compliant manufacturing platform to produce CAR T cells.
One patient’s story of receiving cell therapy treatment (CAR-T cell therapy)
When his lymphoma grew faster than expected, Paul Chae was treated with CAR-T cell therapy. Discover how innovations in technology helped Paul become cancer free.
Workshop: Industrialization of Cell Therapy Manufacturing—Lessons Learned from Biologics
Cell and gene therapy industry experts come together to discuss how the lessons learned from biologics can be applied to advance the industrialization of cell therapy manufacturing.
Scaling non-viral cell therapy approaches for solid tumor treatments
In this article, cell therapy manufacturing leaders from PACT Pharma Inc. and Thermo Fisher Scientific discuss safety and regulatory advantages of non-viral transfection for cell therapy and scaling and automating the manufacturing process.
An innovative approach towards standardizing cell therapy manufacturing
Whether you’re new to cell therapy manufacturing or looking to expand your existing processes and knowledge base, this article highlights emerging technologies for cell therapy manufacturers.
Cell therapy workflow: Integrated solutions from collection to delivery
The journey of the patient from vein-to-vein is a complex process that requires a multitude of products, instrumentation, equipment and regulatory compliant infrastructure.
Download our infoposter to learn more about the development of cell therapies, historical breakthroughs, common challenges, and things to consider through each stage of the workflow.
Cell therapy handbook: Considerations for cell therapy development and manufacturing
A review of the latest methodologies, common practices, resources, applications and more, to support every step of your cell therapy manufacturing workflow.
Cell therapy: Optimizing the vein-to-vein workflow
The patient is at the center of the cell therapy journey. Discover how a GMP-compliant, semiautomated manufacturing platform can result in consistent, efficacious CAR T cell production.
Expanding the cell and gene therapy manufacturing workflow
Download our case study to learn how the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University created efficiencies in cell and gene therapy manufacturing by collaborating with Thermo Fisher Scientific as a single partner.
Better together: Accelerating cell therapy development through collaboration
Discover why collaboration matters, what makes a good partnership, and how you can overcome the challenges of cell therapy manufacturing and scaling on your path to clinical and commercial success.
Finding the right cell therapy collaborator for your specific needs
Whether you’re a large biotech company producing blockbuster therapeutics or a startup biotech looking to bring your innovative and disruptive product to market, this blog post will show you how partnership can help you accelerate cell therapy development—and avoid headaches along the way.
Advances in incubator storage reduce common risks to stem cells
Discover how to reduce the contamination risk, maintain environmental stability, and reduce gas use and evaporation with Thermo Fisher Scientific Cell Locker™ System.
High-performance incubation with certified cleanroom compatibility
Translating innovative cell therapy research into promising products requires the use of carefully controlled incubation environments that provide optimal conditions for cell growth.
Learn how an electronically monitored BSC can provide a strong link in the aseptic processing chain, maintaining safety and quality, and simplifying the compliance process.
Learn how real-time supervision of critical laboratory equipment parameters can boost laboratory efficiency and productivity by reducing sample failures.
Successful cell therapy commercialization starts with QbD
The cell therapy commercialization process doesn’t have to be daunting. Learn to how to make it easier by relying on cell therapy solutions and expert advice.
The importance of controlling the rate of freezing
Discoveries in gene and cell therapies are happening every day. Learn how to achieve seamless transitions from the discovery to the production phase by using a controlled-rate freezer.
Researchers face enormous pressure in maintaining their adherence to cGMP standards. Discover how Thermo Fisher Scientific focuses on simplifying cGMP compliance.